Johnson & Johnson was the top robotics innovator in the clinical trial operations sector in the last quarter. The company filed 54 robotics related patents in the three months ending January. That was down from 114 over the same period in 2021.
It was followed by the Thermo Fisher Scientific with 21 robotics patent applications, Roche (12 applications), and Sartorius (3 applications).
Roche has recently ramped up R&D in robotics. It saw growth of 25% in related patent applications in the three months ending January compared to the same period in 2021 – the highest percentage growth out of all companies tracked with more than 10 quarterly patents in the clinical trial operations sector.
Robotics in Pharma: Filings trends 2021
Please check your email to download the white paper.
Nonetheless, research and innovation in robotics in the clinical trial operations sector has declined in the last year.
The most recent figures show that the number of robotics related patent applications in the industry stood at 34 in the three months ending January – down from 64 over the same period in 2021.
Figures for patent grants related to robotics followed a similar pattern to filings – shrinking from 39 in the three months ending January 2021 to 31 in the same period in 2022.
The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.
Robotics is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.
The figures also provide an insight into the largest innovators in the sector.